Losartan and dapagliflozin combination therapy in reducing uric acid level compared to monotherapy in patients with heart failure
The optimal therapy for reducing uric acid levels in HF patients was the combination of losartan and dapagliflozin, and the effectiveness did not change through sex, T2DM, and dyslipidemia patients.
Authors
- Bảo Lâm Thái Trần (ORCID: https://orcid.org/0000-0002-5349-6359)
- Phong Thanh Pham
- Son Kim Tran (ORCID: https://orcid.org/0000-0002-2384-0278)
- Khoa Dang Dang Tran
- Toan Hoang Ngo (ORCID: https://orcid.org/0000-0002-0688-4754)
- Ngoc Mai Tran (ORCID: https://orcid.org/0000-0002-5061-6562)
- D. Tran (ORCID: https://orcid.org/0000-0002-3355-7521)
- Tuong Le Trong Huynh
- Hoang Minh Tran (ORCID: https://orcid.org/0009-0008-5515-3799)
Institutions
- Can Tho University (VN)
- Can Tho University of Medicine and Pharmacy
Publication Details
- Journal
- PeerJ
- Published
- 2024-11-29
- DOI
- https://doi.org/10.7717/peerj.18595
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72